4.8 Editorial Material

Proteasome malfunction activates the PPP3/calcineurin-TFEB-SQSTM1/p62 pathway to induce macroautophagy in the heart

Journal

AUTOPHAGY
Volume 16, Issue 11, Pages 2114-2116

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/15548627.2020.1816666

Keywords

macroautophagy; PPP3/calcineurin; PSMC2; SQSTM1/p62; TFEB

Categories

Funding

  1. American Heart Association [AHA00182]
  2. National Heart, Lung, and Blood Institute [HL085629, HL072166, HL131667, HL153614, HL124248]

Ask authors/readers for more resources

Proteasome inhibition (PSMI) is known to activate macroautophagy (autophagy hereafter), but the underlying mechanisms remain to be fully delineated. Here we discuss our recent work identifying an important PPP3/calcineurin-TFEB-SQSTM1/p62 pathway in mediating activation of autophagy by PSMI, a compensatory process for the heart with proteasome malfunction. Through increasing PPP3/calcineurin activity and inhibiting MTOR signaling, PSMI promotes the dephosphorylation and thereby nuclear translocation of TFEB, resulting in transactivation of genes in the autophagic-lysosomal pathway (ALP) such asMcoln1andSqstm1. We have discovered that SQSTM1 is required for not only induction of autophagy but also cardiac activation of TFEB by PSMI, unveiling a novel feedforward role for SQSTM1 in TFEB activation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available